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A B S T R A C T
Background: In a recent ecological study among residents living around Belgian nuclear sites (the
NUCABEL study), signiﬁcant increased incidences of thyroid cancer were observed around the two
nuclear facilities with industrial and research activities (Mol-Dessel and Fleurus), prompting further
research.
Methods: The data from the NUCABEL study were reanalysed to test the hypothesis of a gradient in
cancer incidence with increasing levels of exposure from these sites using three measures of surrogate
exposure, being (i) residential proximity, (ii) prevailing wind directions and (iii) simulated dispersion of
radioactive discharges. Single-site focussed hypothesis tests were complemented with Generalized
Additive Models to estimate the exposure-response relationships.
Results: For Mol-Dessel, the results of the focussed hypothesis tests were far from signiﬁcant. For
Fleurus, the p-values were much closer to signiﬁcance with p = 0.05 for Bithell’s Linear Risk Score using
radioactive discharge estimates as surrogate.
Conclusions: The re-analyses refute an association with the nuclear facilities for the site of Mol-Dessel.
For the site of Fleurus, one of Europe’s major production sites of radio-iodines, the results were less
conclusive and further research suggests itself.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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3.0/).1. Introduction
Since the ﬁrst reports on childhood leukemia clusters around
nuclear power plants (NPPs) in the 1980s [1–5], controversy exists
regarding the link between health risks and proximity to nuclear
installations. With the publication of the German KIKK study at the
end of 2007, a large-scale case-control study reporting a 1.6-fold
increase [lower one-sided 95%CI: 1.26] in solid cancers and a 2.2-fold
increase [lower one-sided 95%CI: 1.51] in leukemia among children
living within 5 km of all German NPPs [6–9], the public health
concern about nuclear activities was anew at the centre of attention.
It continued to be a public health polemic in Europe with the
publications of the French [10] and British [11] case-control study.
The French case-control study [10] reported an odds ratio (OR) of
1.9 (95% CI: 1.0–3.3) for acute leukemia among children (<5yrs)
living within 5 km of one the 19 French NPPs. On the other hand, the
British study [11]) obtained a negative estimated risk of childhood
(<5yrs) leukemia and non-Hodgkin lymphoma associated with
residential proximity to a NPP at birth (OR = 0.86, 95% CI 0.49–1.52).e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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at the Institute for Radio-elements in Fleurus, one of Europe’s major
production sites of radio-iodines. During the incident (INES-rating:
3), an estimated gaseous amount of 48GBq of I-131 was released to
the environment [12]. The post-incident investigation indicated
points of serious concern with regard to both the operational safety
and the management of the Fleurus’ site [12,13] and hence, earlier
exposures cannot be ruled out. In response to the incident at Fleurus,
the Belgian Minister of Social Affairs and Public Health commis-
sioned a national epidemiological study to explore health risks
associated with living in the vicinity of nuclear sites. The nuclear
sites under study were the four Belgian facilities with the highest
radiological risk (e.g. Mol-Dessel, Fleurus, Doel, Tihange) and the
French NPP of Chooz, which is close to the Belgian border. To react
promptly, a multi-disciplinary research group decided that an
exploratory ecological study using readily available data sources
should be conducted focussing on childhood leukemia and thyroid
cancer. Leukemia is the typical health outcome for studies on health
risks among residents living close to nuclear sites [14]. Nevertheless,
thyroid cancer is a health outcome of interest as well, known to occur
after exposure to radioactive isotopes of iodine [15,16], although
latency times are generally long [17]. As a result, the current study
allows investigating the potential health effects of (possibly
undetected and unreported) past exposures, but not of the 2008
Fleurus incident itself.
The NUCABEL study was carried out by the Belgian Scientiﬁc
Institute of Public Health, the Federal Agency for Nuclear Control
(FANC) and the Belgian Cancer Registry (BCR). Earlier ﬁndings [13]
indicated signiﬁcantly increased incidences of thyroid cancer among
residents living in the 20 km proximity area around the two Belgian
sites with nuclear research- and industrial activities, (i.e. Mol-Dessel
and Fleurus), whereas no increased risks were found around the
NPPs of Doel, Tihange, or the Belgian territory around the French NPP
of Chooz. In the 20 km proximity areas of Mol-Dessel and Fleurus,
incidence rate ratios (RR) of 1.19 (95%CI: 1.02–1.38) and 1.17 (95%CI:
1.04–1.33), respectively, were observed. To investigate whether
there may be an association between thyroid cancer incidence and
the nuclear sites, supplementary analyses were commissioned forFig. 1. Map of Belgium indicating three regions, 589 municipal communes with their c
proximity regions.the sites of Mol-Dessel and Fleurus. First, the hypothesis of a gradient
in cancer incidence with increasing levels of exposure was tested
using three measures of surrogate exposure, i.e. (i) residential
proximity, (ii) prevailing wind directions and (iii) simulated
dispersion of radioactive discharges. Second, the hypothesis tests
were complemented with the estimation of the exposure-response
relationships. The results of childhood leukaemia of the NUCABEL
study are described in [18].
2. Materials and methods
2.1. Data
Thyroid cancer incidence data by commune, age and sex were
received from the Belgian Cancer Registry. Data were available for
the incidence years 2000–08 for the Flemish Region and for the
diagnosis years 2004–08 for the Walloon and Brussels-Capital
Region. In 2008, 754 people were diagnosed with thyroid cancer in
Belgium. Of them, 546 were women and 208 were men, making it
the 13th most common cancer among women, even though
uncommon among men [19]. Thyroid cancer incidence statistics by
age, sex, time and geographical location are given in [13].
Population data were obtained from the Belgian Directorate-
general Statistics and Economic Information for every year from 2000
to 2008. For each year, population counts stratiﬁed by commune, 5-
year age groups and sex were obtained for January 1st. In 2008,
Belgium had a population of 10,666,866 inhabitants, divided over the
Flemish (6,161,600), Walloon (3,456,775) and Brussels-Capital Region
(1,048,491). The smallest administrative level at which age- and sex-
speciﬁc data are available at the moment in Belgium are the
communes. Belgium counts a total of 589 communes with a median
surface of 51.8 km2, divided over the Flemish (n = 308), Walloon
(n = 262) and Brussels-Capital Region (n = 19) (see Fig. 1).
2.2. Nuclear sites
The nuclear sites of Mol-Dessel and Fleurus are nuclear facilities
classiﬁed in Class 1 (highest radiological risk category according toentroids and the location of the site of Mol-Dessel and Fleurus, with their 20 km
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within the Flemish region of Belgium and Fleurus within the
Walloon region. Both sites are a potential source of radioactive
iodine isotopes. Several facilities in nuclear research and nuclear
industry are situated on the sites (Table 1). The nuclear site of Mol-
Dessel primarily consists of the Belgian Nuclear Research Centre
(SCK-CEN), the Class I operator with the highest potential source
term at the site. The nuclear site of Fleurus primarily consists of the
Institute for Radioelements (IRE), one of Europe’s major production
sites of radio-iodines for commercial use. Both sites are still in
activity (Table 1). In line with the literature, the proximity area of a
nuclear site was deﬁned as the area covered by all communes of
which the centroid lies within the circle with a 20 km radius
around the site. The locations of the sites were determined by geo-
locating the reactor buildings [18].
2.3. Surrogate exposure
Three different measures of surrogate exposure to radionuclide
gaseous discharges were used, i.e. (i) residential proximity to the
nuclear site, (ii) prevailing wind directions and (iii) simulated
radioactive discharges based on mathematical modelling. TheTable 1
Description of the nuclear sites Fleurus and Mol-Dessel, Belgium.
Main activity Rea
Fleurus
IREa Production of radionuclides for
medicine and industry
Sterigenics Sterilization of medical
equipment and irradiation of
foodstuffs
NIRAS Clean-up of former Best Medical
Belgium (BMB) plant:
production of radionuclides for
medical applications from 1971–
2012 (ﬁrst IRE, then MSD-
Nordion, then BMB)
NTP Production of Ir-192 sources for
industry
IBA Pharma Production of Pd-103 for medical
applications
Mol-Dessel
Belgoprocess Operational waste Management 
SCK-CENa Scientiﬁc and technological
research (4 reactors)
BR1
BR2
BR3
VEN
Belgian Underground Research
Laboratory
Laboratoria 
IRRMa Metrology and applied research 
Belgonucle´aire Production of MOXb fuel for
nuclear power plants
FBFCa-international Production of fuel assemblies for
PWRsb based on UO2 and MOXb
fuels
a IRE = Institute for Radio-Elements; SCK-CEN = Belgian Nuclear Research Centre; IRR
Fabrication Combustible.
b PWR = Pressurized-water reactor; BR = Belgian Reactor; VENUS = Vulcan Experiment
Oxides.
MWe: Megawatt electric; electric output of a power plant in megawatt, MWth: Megawlevels of surrogate exposure were determined at commune level
for all communes within the proximity area. In particular,
residential proximity was calculated as the distance between
the location (in Lambert 1972 coordinates) of the nuclear sites and
the communes’ centroids. To calculate prevailing wind directions,
data on wind direction and–velocity from 2003–08 were used as
collected by survey stations around the nuclear sites. Measure-
ments were discarded when the wind velocity was below 0.2 m/s
because low wind velocity is associated with unstable and
continuously changing wind directions. The measurements above
0.2 m/s were used to calculate 16-sector compass roses. For every
commune’s centroid, the frequency (in %) of the wind blowing from
the site towards the commune was then calculated. Finally,
simulated radioactive discharges from the nuclear plants based on
mathematical dispersion modelling were calculated. More speciﬁ-
cally, I-131 discharges were simulated because both sites are
potential sources of radioactive isotopes of iodine. This is
particularly true for the site of Fleurus, which is one of the major
production sites of commercially available radio-iodines in Europe.
The exposures were simulated using Hotspot [21], providing
analytical solutions to the transport and diffusion equations for
short duration (puffs) or continuous (plumes) releases ofctors Max.
power
Period of
operation
Speciﬁcations
1971- Mo-99, I-131, (Xe-133)
1978 Co-60
2012- 2 cyclotrons and radionuclide
production labs (out of
operation)
1971- Ir-192-
2002–2004 Pd-103 by cyclotron
site1:
1984- site2:
1989-
ex-Eurochemic plant (1966) ex-
SCK plant (1956)
b 4 MWth 1956- Air-cooled, graphite
b 120 Mwth 1963- Research reactor
b 10.5 MWe
dismantled
1962–1987 PWR-dismantled,
USb zero power
critical
assembly
1964- Experimental reactor, zero-
power critical facility
1983 Study of storage conditions of
radioactive waste in deep
geological formations
1960 High and middle radioactivity
laboratoria, mainly for nuclear
fuel research
1960- Laboratories, particle
accelerators
1973–2006 Under dismantling
1963-
M = Institute for Reference Materials and Measurements; FBFC = Franco-Belge de
al Nuclear Study; HADES = High Activity Disposal Experimental Site; MOX = Mixed
att thermal; overall power of a nuclear reactor in megawatt.
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upwind and cross-wind direction takes the form of a Gaussian
curve, with the maximum concentration in the centre of the plume.
The model further assumes that a steady state exists regarding the
radioactive discharges and the meteorological conditions. Calcula-
tions were carried out for standard releases (total activity:
1015 Bq), assuming average meteorological conditions (wind
speed: 3 m/s; annual percentage rain fall: 5%) and site-speciﬁc
effective release heights (Fleurus: 35 m; Mol-Dessel: 80 m). The
simulated exposures were ﬁrst expressed as a function of distance
from the source. By multiplying these simulations by the wind
direction frequencies (in %), the ﬁnal exposure simulations at every
commune’s centroid were obtained.
2.4. Statistical methods
Single-site analyses were carried out to test the hypotheses of
increasing thyroid cancer incidence with increasing levels of
surrogate exposure by means of two focussed hypothesis tests, i.e.
the conditional form of Stone’s Likelihood ratio test [22] and
Bithell’s Linear Risk Score (LRS) test [23]. The advantage of Stone’s
test is that it is invariant to monotonic transformations of the
exposure variable and as such, avoids the need to specify the
exposure-response relationship. For the Bithell’s Linear Risk Score
(LRS) tests, scores ui are to be deﬁned by the user as a function of
exposure wi. These tests are, compared to Stone’s test, more
powerful in case the scores properly reﬂect the ‘exposure’ effect,
but assumptions are (implicitly) made regarding the scale of the
‘exposure’ effect when deﬁning the scores ui. For the current
analyses, three different types of focussed hypothesis tests were
carried out: (a) the conditional form of Stone’s test using the
inverse residential distance from nuclear site, prevailing winds and
estimated discharges as surrogates of exposure, (b) Bithell’s LRS
test with these surrogates of exposure as scores ui, and (c) Bithell’s
LRS test with corresponding ranks. P-values were obtained by
Monte Carlo simulation from the multinomial distribution with
R=5000 iterations.
To complement the focussed hypothesis tests, Generalized
Additive Models (GAMs) [24], which are an extension of the
Generalized Linear Models (GLMs) [25], were used to estimate the
shape of the exposure-response relationships. A GLM, of which
Poisson regression is a special case, relates a univariate response
variable to a linear combination of predictor variables, whereas a
GAM relates a univariate response to unknown smooth functions
of some predictor variables. As such, the generality of a GLM is
kept, but the polynomial structure of the additive effects is relaxed.
To explain, let us ﬁrst revisit the Poisson regression model used in
[13]. The model uses the quasi-likelihood approach with Pearson-
based overdispersion parameter w to compare cancer incidences
between areas while accounting for several covariates. Let Yij
denote the observed number of disease cases within area i, with
i = 1, 2, . . ., l, and within age-sex speciﬁc stratum j, with j = 1, 2, . . .,
J. Further, let li j ¼ E Yi j
 
denote the expected number of diseaseTable 2
Estimates (and 95% CI) of the constant Rate Ratio of living versus not living in the vicinity
Linear Risk Score test (LRS) and Bithell’s Linear Risk Score test with corresponding ranks (
to nuclear site, (2) prevailing winds and (3) radioactive discharge estimates based on m
Rate ratioa Proximity 
Est. 95% CI Stone LRS LRS2
Fleurus 1.17b [1.04;1.33] .50 .36 .33 
Mol-Dessel 1.19b [1.02;1.38] .35 .18 .19 
a Constant Rate Ratio is given by exp(b1) within the Poisson regression model given
b Signiﬁcant at a = 0.05cases being modelled using Poisson regression as
Yi j Poisson li j
 
log li j
  ¼ log ni j
 þ
Xp
k¼1
bkXk i j ¼ log ni j
 þ hi j; (1)
with the annual population size in stratum j of area i as offset
term nij and with linear predictor
hi j ¼ b0 þ b1 proxi j þ b2sexi j þ b3agei j þ b4age2i j þ b5 age  sexð Þi j
þ b6regi j þ b7yeari j þ b8 reg  yearð Þi j
being a function of residential proximity to a nuclear site (i.e. living or
not living within the 20 km proximity area), sex, 5-year age groups,
region (i.e. Flemish Region versus Walloon/Brussels-Capital Region)
and diagnosis year. By exponentiation of the parametersb associated
with the binary risk factors, Rate Ratios (RRs) are obtained.
When relaxing the assumption of a constant Rate Ratio for
living in the proximity area of a nuclear site versus not living in the
proximity area, the GLM given above in Eq. (1) gives rise to the
following GAM
Yi j Poisson li j
 
log li j
  ¼ log ni j
 þ f Wi j
 þ
Xp
k¼2
bkXk i j ¼ log ni j
 þ h0i j;
(2)
with the previously assumed constant effect b1 being now
assumed to be a smooth function f(.) of surrogate exposure W,
implying that the RR is no longer assumed to be constant, but
allowed to vary smoothly as a function of exposure. The smooth
function f(.) is taken to be a P-splines function [26], being a
function of an excessive number of equally spaced univariate B-
splines [27] and an additional discrete smoothness penalty to
correct for overﬁtting. In particular, a B-splines basis of 10 B-
splines of third degree and second order smoothness penalty were
used. The smoothness parameter was optimally chosen from the
grid L = 105 with p ¼ 3; 2; 1; 0; 1; 2; 3; 4; 5f g using the Quasi-
likelihood Information Criterion (QIC) [25].
3. Results
Based on the constant Rate Ratio model (Table 2), signiﬁcantly
increased thyroid cancer incidences were observed around the
nuclear sites of Mol-Dessel and Fleurus. The focussed hypothesis
tests did not yield signiﬁcant results. For Mol-Dessel, all p-values
were far from signiﬁcance. For Fleurus, the p-values were close to
signiﬁcance when prevailing winds and radioactive discharge
estimates were used as surrogates.
For the site of Mol-Dessel (Fig. 2), the estimated exposure-
response curves using residential proximity indicated a (non-
signiﬁcant) positive gradient of thyroid cancer incidence. The
estimated exposure–response curve based on wind direction did
not suggest a gradient. The estimated exposure–response curve
based on mathematical modelling of I-131 exposure suggested a (20 km circle) of the nuclear site and the results (p-values) of Stone’s test, Bithell’s
LRS2) for the different measures of surrogate exposure, i.e. (1) residential proximity
athematical modelling.
Wind I-131
Stone LRS LRS2 Stone LRS LRS2
.09 .09 .27 .10 .18 .05
.51 .43 .43 .42 .20 .21
 in Eq. (1).
Fig. 2. Mol-Dessel: Rate Ratios (RRs) and 95% CI (gray area) of thyroid cancer incidence within the 20 km proximity area as a smooth function of (a) residential proximity to the
nuclear site,(b) prevailing wind directions and (c) simulated I-131 discharges. The horizontal dashed line represent the constant RR. The dots represent the commune-speciﬁc
RRs and the corresponding 95% CIs are represented by the lines
* Data source: Belgian Cancer Registry.
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well, although driven by one commune (Dessel commune-speciﬁc
RR = 1.87; 95%CI = [0.84;4.17]).
For the site of Fleurus, the estimated exposure-response curve
did not show any evidence for a gradient in thyroid cancer
incidence with decreasing distance (Fig. 3). The exposure–
response relationship as a function of wind direction suggested
a gradient in thyroid cancer incidence. However, this was not
conﬁrmed by the focussed hypothesis tests. The discharge based
exposure–response relationship showed an increase at the lower
exposure levels, but a drop at the highest levels. This drop was
driven by the commune of Fleurus (commune-speciﬁc RR = 0.86;
95%CI = [0.45;3.19]). These ﬁndings were consistent with the
results from the focussed hypothesis tests. Only Bithell’s LRS test
based on ranks yielded signiﬁcant results because it is, compared
to Stone’s test, the most powerful test to detect linearity and is,
compared to Bithell’s LRS test based on exposure levels, the most
robust to outliers in the exposure variable, and hence, the least
inﬂuenced by the ‘outlying’ result from the commune of Fleurus.
4. Discussion
The objective of the current study was to further examine the
earlier positive ﬁndings from the NUCABEL study [13], indicatingsigniﬁcantly increased incidences of thyroid cancer around the two
Belgian nuclear sites with industrial and research activities, i.e.
Mol-Dessel and Fleurus. In particular, the hypothesis of a gradient
in cancer incidence with increasing levels of radiation exposure
from these sites was investigated. However, these levels are often
below the detection limit of the routine environmental monitoring
in Belgium, by which background radiation is predominantly
measured. Therefore, the radiological discharges from the sites, in
particular the gaseous discharges, were considered. Unfortunately,
the non-aggregated measurements are not publicly available,
necessitating the use of surrogates.
Three different surrogates of radiological gaseous exposure
were employed; (i) residential proximity, (ii) prevailing wind
directions, and (iii) simulated radioactive exposure based on
mathematical dispersion modelling of the discharges. Each
measurement has its pro’s and con’s. The use of residential
proximity as surrogate exposure assumes an isotropic and
isotonic decrease of exposure with distance. However, although
commonly used [28,29], this approach ignores among others the
impact of wind direction and is therefore radio-ecologically not
plausible [30]. The same holds true when using prevailing wind
directions as surrogate of exposure, by which the impact of
distance is ignored. The radio-ecologically most plausible
surrogates of exposure are the ones using radioactive exposure
Fig. 3. Fleurus: Rate Ratios (RRs) and 95% CI (gray area) of thyroid cancer incidence within the 20 km proximity area as a smooth function of (a) residential proximity to the
nuclear site,(b) prevailing wind directions and (c) simulated I-131 discharges. The horizontal dashed line represent the constant RR. The dots represent the commune-speciﬁc
RRs and the corresponding 95% CIs are represented by the lines
* Data source: Belgian Cancer Registry.
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take into account the combined effects of distance and wind
direction as well as the physical characteristics of radionuclide
dispersion. However, this last surrogate is the most prone to
misclassiﬁcation errors as it combines (the misclassiﬁcation
errors of) distance and wind direction. Finally, note that more
detailed radionuclide dispersions models exist [31,32]. However,
such detailed dispersion models would be off-balance with the
size of the geographical unit of analysis (communes’ level) used in
the current study.
In addition to the different surrogates of exposure, different
statistical methods were exploited. In particular, three different
focused hypothesis tests (i.e. Stone’s test, Bithell’s LRS test with
levels of surrogate exposure and Bithell’s LRS test with ranks) were
used, all ranging differently with respect to the trade-off between
power and the need to correctly specify the exposure–response
relationship. Finally, to complement the focused hypothesis tests,
the exposure–response relationships were estimated using GAMs
allowing the Rate Ratio for living versus not living in the proximity
area of a nuclear site to vary smoothly as a function of exposure. To
our knowledge, this is the ﬁrst use of this type of models within the
context of point-source exposure modeling. This approach of
estimating the exposure-response relationship using GAMs is anextension of the Poisson regression model, the use of which has
been advocated within this context [8,28].
The use of different statistical methods and measures of
surrogate exposure has an important added value. Since every
method and every surrogate of exposure inherently relies on some
assumptions, the use of multiple methods/surrogates of exposure
reduces the dependence of the (combined) results on the
assumptions and provides nuanced and complementary insights.
Consistent results strengthen the conﬁdence of a result to be ‘‘true’’
as opposed to a ‘‘spurious’’ result driven by assumptions.
The results from the multiple methods/measures of exposure
approach should be regarded in the light of the ecological design of
the study and its drawbacks. The ecological design entails that
population-level data are compared rather than individual-level
data. The most pertinent drawbacks of the ecological design
include the ecological bias (i.e. associations at population-level do
not necessarily reﬂect associations at individual-level) and the
failure to account for important (individual-level) variables. For
example, the current study does not account for individual
migration patterns, resulting in exposure misclassiﬁcation. Anoth-
er important source of exposure misclassiﬁcation is the size of the
geographical areas that correspond to the smallest administrative
level for which health data are (currently) available in Belgium
K. Bollaerts et al. / Cancer Epidemiology 39 (2015) 48–5454(i.e. commune level). Such exposure misclassiﬁcation, even when
non-differential, may lead to spurious positive or negative results
[33–35]. For all these reasons, the evidence from ecological studies
is generally considered as weaker when compared to e.g. well-
conducted (large scale) case-control studies [28], which are more
resource- and time intensive compared to ecological studies. A way
to enhance statistical power, is by conducting multi-site analysis
by grouping nuclear sites. However, we opted not to do so because
the sites of Mol-Dessel and Fleurus are characterized by different
types of nuclear activities.
The NUCABEL study did not allow investigating the health
effects of the Fleurus 2008 incident itself as a result of the
ecological design used and the time period of the available cancer
incidence data (2000/2004-2008). Instead it allowed investigating
the potential health effects of (possibly undetected or unreported)
past exposures. As the timing of such possible past exposures is
unknown, the cross-section over all ages was taken. The two main
pathways of exposure from release of radionuclides in the
atmosphere by nuclear installations are gamma radiation and
ingestion of radionuclides through food contamination. Because
the ecologic design was used, only the ﬁrst pathway could be taken
into account. However, food contamination is generally not
considered a geographical risk factor in Belgium as a result of
the Belgian open food economy.
Taking all these considerations into account, we conclude that
the surrogate-exposure analyses refute the earlier positive ﬁnding
for the site of Mol-Dessel. For the site of Fleurus, the results were
less conclusive. The inconclusive results for the site of Fleurus, one
of the major production sites of radioiodines in Europe, ask for
further research. We recommended preparing cancer data at
smaller geographical level. These data are expected to be available
in the near future, and will allow repeating the analyses with
greater geographical detail and for an extended time period.
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